Global Exoskeleton Market Analysis/Research Report 2023-2035: Trexo Robotics Partners with Keystone Education Group to Bring Robotic Gait Trainer to Children with Autism – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The

The Global Exoskeleton Market is estimated to be worth over USD 20 billion in 2035 and is expected to grow at compounded annual growth rate (CAGR) of 23.1% during the forecast period (2023-2035)

The primary objective of this market report is to conduct a comprehensive market forecast analysis, aiming to estimate both the current market size and the future opportunities for exoskeleton companies over the next decade. Through an in-depth examination of historical market data within the industry, we have sought to gain a profound understanding of the evolutionary market trends.

Beyond the healthcare industry, exoskeleton technology is serving to augment the performance as well as prevent work-related accidents of workers employed in a wide range of industries, such as construction, logistics, vehicle factory, aircraft manufacture, shipyard, automotive / metal mechanics industry, foundry, aeronautics, maintenance, and other factory works.

Despite their widespread benefits, several factors, including the cost barriers and lack of awareness limit the adoption of these devices amongst users. In order to ensure wider acceptance, exoskeleton companies are focusing their R&D efforts to lower the cost of exoskeleton, as well as integrating technologies such as cloud computing, deep learning, smart sensors and artificial intelligence in their exoskeleton portfolio.

As the exoskeleton technology advances and the cost of exoskeletons decreases, and the stakeholders recognize the positive return on investment (ROI) on exoskeleton products (owing to higher benefit-cost ratio), the adoption of this nascent exoskeleton technology across various industries is poised to grow, ultimately driving the growth of the global exoskeleton market during the forecast period.

The majority of the exoskeleton companies are headquartered in North America, followed by those based in Europe. Consequently, nearly 40% of the global market for exoskeletons is anticipated to be captured by exoskeleton companies based in North America, in 2035. According to data from the Centers for Disease Control and Prevention (CDC), it is estimated that approximately 61 million people in the United States live with various forms of impairment, and among these individuals, mobility disabilities constitute a significant portion, accounting for 13.7% of the disabled population.

As per the projections of the United States Census Bureau (USCB), the US population aged 65 and older is expected to more than double by the year 2050. This demographic shift has the potential to significantly increase the demand for medical exoskeletons throughout the nation. Further, the exoskeleton market in Asia-Pacific is expected to grow at a relatively high CAGR of ~30% during the forecast period (2023-2035).

Market Trends: Partnerships and Collaborations on the Rise for Medical Exoskeleton

In recent years, several partnerships have been inked by industry stakeholders, in order to consolidate their presence in this field. It is worth highlighting that nearly 60% of deals were forged in the last three years (since 2020). Interestingly, most of the agreements were distribution agreements (26%), followed by product / technology development agreements (15%).

In July 2023, Wandercraft entered into an agreement with Brazilian Health authority to provide its two Atalante X exoskeletons at Lucy Montoro, a Brazilian neurological rehabilitation institution to support patient rehabilitation and medical research. Further, in June 2023, Trexo Robotics entered into a commercialization agreement with Keystone Education Group to use their Trexo Robotic Gait Trainer exoskeleton for children with autism spectrum disorder.

The report features detailed transcripts of interviews held with the following industry stakeholders:

• Co-Founder and Chief Executive Officer, Small Company, Spain
• Director of Business Planning and Development, Small Company, Japan
• Vice President of Sales and Marketing, Small Company, USA
• Marketing and Design Manager, Small Company, Canada
• Founder and Director, Small Company, India

Key Exoskeleton Companies Profiled

• Bionic Yantra
• CYBERDYNE
• Ekso Bionics
• ExoAtlet
• Fourier Intelligence
• Gloreha
• Guangzhou Yikang Medical Equipment
• Hexar Humancare
• Hocoma
• MediTouch
• Milebot Robotics
• Myomo
• Neofect
• NextStep Robotics
• Panasonic
• ReWalk Robotics
• Rex Bionics
• Roam Robotics
• Trexo Robotics
• Tyromotion
• U&O Technologies

Key Attributes:

Report Attribute	Details
No. of Pages	425
Forecast Period	2023 – 2035
Estimated Market Value (USD) in 2023	$1.67 Billion
Forecasted Market Value (USD) by 2035	$20.22 Billion
Compound Annual Growth Rate	23.1%
Regions Covered	Global

Key Topics Covered:

1. PREFACE

2. RESEARCH METHODOLOGY

2.1. Chapter Overview

2.2. Research Assumptions

2.3. Project Methodology

2.4. Forecast Methodology

2.5. Robust Quality Control

2.6. Key Market Segmentations

2.7. Key Considerations

2.7.1. Demographics

2.7.2. Economic Factors

2.7.3. Government Regulations

2.7.4. Supply Chain

2.7.5. COVID Impact/Related Factors

2.7.6. Market Access

2.7.7. Healthcare Policies

2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

3.1. Chapter Overview

3.2. Market Dynamics

3.2.1. Time Period

3.2.1.1. Historical Trends

3.2.1.2. Current and Forecasted Estimates

3.2.2. Currency Coverage

3.2.3. Foreign Exchange Impact

3.2.4. Recession

3.2.5. Inflation

4. EXECUTIVE SUMMARY

5. INTRODUCTION

5.1. Chapter Overview

5.2. Overview of Exoskeleton

5.3. History of Exoskeleton

5.4. Classification of Exoskeleton

5.5. Applications of Exoskeleton

5.6. Features of Exoskeleton

5.7. Limitations of Exoskeleton

5.8. Future Perspectives

6. MEDICAL EXOSKELETON: MARKET LANDSCAPE

6.1. Chapter Overview

6.2. Medical Exoskeleton: Overall Market Landscape

6.3. Medical Exoskeleton: Developer: Landscape

7. NON-MEDICAL EXOSKELETON: MARKET LANDSCAPE

7.1. Chapter Overview

7.2. Non-Medical Exoskeleton: Overall Market Landscape

7.3. Non-Medical Exoskeleton: Developer Landscape

8. MEDICAL EXOSKELETON: PRODUCT COMPETITVENESS ANALYSIS

8.1 Chapter Overview

8.2. Assumptions and Key Parameters

8.3. Methodology

8.4. Medical Exoskeleton: Product Competitiveness Analysis

9. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES

9.1. Chapter Overview

9.2. CYBERDYNE

9.2.1. Company Overview

9.2.2. Financial Information

9.2.3. Product Portfolio

9.2.4 Recent Developments and Future Outlook

9.3. Ekso Bionics

9.4. ExoAtlet

9.5. Fourier Intelligence

9.6. Gloreha

9.7. Guangzhou Yikang

9.8. Hexar Humancare

9.9. Hocoma

9.10. Panasonic

9.11. Tyromotion

10. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES

10.1. Chapter Overview

10.2. Bionic Yantra

10.3. MediTouch

10.4. Milebot Robotics

10.5. Myomo

10.6. Neofect

10.7. NextStep Robotics

10.8. ReWalk Robotics

10.9. Rex Bionics

10.10. Roam Robotics

10.11. Trexo Robotics

10.12. U&O Technologies

11. MEDICAL EXOSKELETON: PARTNERSHIPS AND COLLABORATIONS

11.1. Chapter Overview

11.2. Partnership Models

11.3. Medical Exoskeleton: List of Partnerships and Collaborations

12. PATENT ANALYSIS

12.1. Chapter Overview

12.2. Scope and Methodology

12.3. Exoskeleton: Patent Analysis

12.4. Exoskeleton: Patent Benchmarking

12.5. Leading Players by Number of Citations

13. BLUE OCEAN STRATEGY

13.1. Overview of Blue Ocean Strategy

13.1.1. Red Oceans

13.1.2. Blue Oceans

13.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy

13.1.4. Medical Exoskeleton: Blue Ocean Strategy and Shift Tools

13.1.4.1. Strategy Canvas

13.1.4.2. Pioneer-Migrator-Settler (PMS) Map

13.1.4.3. Buyer Utility Map

14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

14.1. Chapter Overview

14.2. Market Drivers

14.3. Market Restraints

14.4. Market Opportunities

14.5. Market Challenges

14.6. Conclusion

15. GLOBAL EXOSKELETON MARKET

15.1. Chapter Overview

15.2. Forecast Methodology and Key Assumptions

15.3. Global Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

15.4. Key Market Segmentations

15.5. Dynamic Dashboard

16. EXOSKELETON MARKET, BY BODY PART COVERED

16.1. Chapter Overview

16.2. Forecast Methodology and Key Assumptions

17. EXOSKELETON MARKET, BY MODE OF OPERATION

17.1. Chapter Overview

17.2. Forecast Methodology and Key Assumptions

18. EXOSKELETON MARKET, BY THEIR FORM

18.1. Chapter Overview

18.2. Forecast Methodology and Key Assumptions

19. EXOSKELETON MARKET, BY THEIR MOBILITY

19.1. Chapter Overview

19.2. Forecast Methodology and Key Assumptions

20. EXOSKELETON MARKET, BY END USERS

20.1. Chapter Overview

20.2. Forecast Methodology and Key Assumptions

21. EXOSKELETON MARKET, BY GEOGRAPHY

21.1. Chapter Overview

21.2. Forecast Methodology and Key Assumptions

For more information about this report visit https://www.researchandmarkets.com/r/2f21c7

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900